Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Infinity Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (66)	8/26/2006 2:01:08 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 210

heh, I think it is: Every bit of stock action up until a Novartis milestone, or 609 entering the clinic is noise. There will be a couple steps forward, a step back--over and over again. On balance shares will gradually work there way over to stronger and stronger hands. There is a presentation dated August 16th on the SEC website. Most of it is charts of preclinical tumor graft experiments and such--I trust that crap about as far as I can spit. Ten years ago I was dazzled by Targeted Genetics' presentations with xenograft lab rats and stuff--maybe a Rick or a Peter or one of those guys can fine a single slide that means something to them, not me. However, the list of venture capitalists I like, it is a nice reminder of the quality of investors behind Infinity: Venture Capitalists • Prospect Venture Partners • Venrock Associates • Advent Venture Partners • HBM BioVentures • Vulcan Ventures • Novartis BioVentures • Wellcome Trust • POSCO BioVentures • Tallwood • Alexandria Equities • Lotus BioScience Pharmaceutical Companies • Amgen • Novartis • J&J Now, does INFI warrant a 300M marketcap when it starts trading? Maybe, maybe not--anything between 200M and about 500M is fair. But the VC investors in Infinity surely expect a three to five bagger over three to five years. I'll ride along with them. Meanwhile some of the daytraders and swingtraders will extract a little profit--but only from each other. The PDUFA type traders will do good, but not necessarily any better than a buy and hold type. The VC's will sit back and relax. Probably some of the managment staff will leak out a few shares to buy tuition and vacations, but that is noise too. That said, how nice it is that dpii is above $3!